Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,706
Closed -$215K 351
2019
Q3
$215K Buy
2,706
+33
+1% +$2.59K 0.06% 335
2019
Q2
$224K Sell
2,673
-348
-12% -$27.7K 0.07% 321
2019
Q1
$239K Sell
3,021
-63
-2% -$4.6K 0.06% 325
2018
Q4
$206K Sell
3,084
-1,583
-34% -$110K 0.06% 331
2018
Q3
$373K Buy
4,667
+74
+2% +$5.53K 0.05% 348
2018
Q2
$309K Sell
4,593
-12
-0.3% -$871 0.04% 383
2018
Q1
$354K Buy
4,605
+48
+1% +$3.55K 0.05% 348
2017
Q4
$311K Sell
4,557
-61
-1% -$4.05K 0.04% 383
2017
Q3
$289K Buy
4,618
+222
+5% +$13.3K 0.04% 382
2017
Q2
$244K Buy
4,396
+1
+0% +$52 0.04% 413
2017
Q1
$221K Sell
4,395
-31,524
-88% -$1.54M 0.04% 436
2016
Q4
$1.78M Buy
35,919
+31,014
+632% +$1.57M 0.32% 80
2016
Q3
$257K Buy
4,905
+341
+7% +$16.7K 0.05% 380
2016
Q2
$204K Buy
+4,564
New +$198K 0.04% 423

Other funds holding XYL

ClearArc Capital's XYL Position: Q4 2019 in Review

ClearArc Capital sold out of Xylem (XYL) in Q4 2019, closing a stake of 2,706 shares — an estimated $215K sold.

ClearArc Capital first reported a position in XYL in Q2 2016 and held it in 14 quarters. The position peaked at $1.78M in Q4 2016. 710 funds tracked by Wall St. Rank hold XYL as of Q4 2019.

  • ClearArc Capital reported no remaining Xylem position as of Q4 2019 after selling out during the quarter.
  • ClearArc Capital sold 2,706 Xylem shares in Q4 2019, an estimated $215K.
  • ClearArc Capital first reported a position in Xylem in Q2 2016 and held it in 14 quarters.
  • ClearArc Capital's Xylem position peaked at $1.78M in Q4 2016.
  • 710 funds tracked by Wall St. Rank held Xylem as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.